Portfolio
Our team has completed portfolio company investments in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology spaces. We have backed multiple market leaders, including the selection of current and exited portfolio companies highlighted here.
Adams Respiratory Therapeutics, Inc.
Adams was a specialty pharmaceutical company focused on late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Sector
Specialty Pharma
Status
Exited | IPO; subsequently acquired by Reckitt Benckiser
Alphatec Spine, Inc.
Alphatec Holdings, Inc. (Nasdaq: ATEC), through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation MachineTM is focused on developing new approaches that integrate seamlessly with the company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine.
Sector
Medtech and Medical Devices
Status
Current
Website
https://atecspine.com/
Atritech, Inc.
Atritech developed WATCHMAN™, an implantable device for preventing stroke in atrial fibrillation patients.
Sector
Medtech and Medical Devices
Status
Exited | Acquired by Boston Scientific
Coherex Medical, Inc.
Coherex developed the WaveCrest® Left Atrial Appendage (LAA) Occlusion System, designed to permanently occlude the LAA in high-risk atrial fibrillation (Afib) patients to help reduce the incidence of stroke.
Sector
Medtech and Medical Devices
Status
Exited | Acquired by Biosense Webster/J&J
DocMatter
DocMatter has developed a global medical community platform designed to support the health and well-being of every human being. The company’s platform allows for medical learning and information sharing by leveraging the collective knowledge and experience of peers, as well as that of thought leaders from leading institutions and practices around the world, resulting in improved patient care through collaboration.
Sector
Healthcare Services and Technology
Status
Current
Website
https://www.docmatter.com/
electroCore, Inc.
electroCore, Inc. (Nasdaq: ECOR) is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
Sector
Medtech and Medical Devices
Status
Current
Website
https://www.electrocore.com/
Exagen, Inc.
Exagen (Nasdaq: XGN) is a leading provider of autoimmune diagnostic, prognostic, and monitoring testing solutions. Exagen is a patient-focused, discovery-driven organization built on the success of AVISE testing and is investing in its product pipeline to support patients throughout their autoimmune diagnosis and treatment journeys. The goal at Exagen is to assist patients, physicians, and payors by enabling precision medicine.
Sector
Biotechnology
Status
Current
Website
https://exagen.com
Genoptix, Inc.
Genoptix is a leading clinical oncology laboratory specializing in hematology and solid tumors, and operates one of the largest hematopathology centers in the U.S., providing personalized and comprehensive diagnostic services with a specialization in diagnosing cancers and disorders in bone marrow, blood and lymph nodes, as well as in solid tumor workups using molecular testing.
Sector
Healthcare Services and Technology
Status
Exited | IPO; subsequently acquired by Novartis
Website
https://genoptix.com
Ikano Therapeutics, Inc.
Ikano developed Midazolam Nasal Spray (USL261) for acute repetitive seizures.
Sector
Specialty Pharma
Status
Exited | Acquired by Upsher Smith Laboratories
Impulse Monitoring, Inc.
Impulse provided remote, real-time neurophysiology monitoring during spinal and cranial surgeries, procedures that present direct risk to the nervous system.
Sector
Healthcare Services and Technology
Status
Exited | Acquired by NuVasive
Neurolens, Inc.
Neurolens partners with optometrists to provide the first prescription lenses that add a contoured prism to bring the eyes into alignment. Contoured prism has been shown in studies to relieve the headaches, neck/shoulder pain and eyestrain that many people experience when using digital devices, reading or doing detail work. Patient satisfaction surveys show 93 percent of patients respond positively to their Neurolenses®.
Sector
Medtech and Medical Devices
Status
Current
Website
https://www.neurolens.com
OrthoSensor, Inc.
A leader in Sensor-Assisted Total Joint Arthroplasty, OrthoSensor develops and commercializes intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals. The company’s intelligent orthopedic devices utilize advanced proprietary sensor and communications technologies, coupled with the company’s innovative software products, to facilitate evidence-based decisions in orthopedic surgery with a goal of improving patient outcomes and reducing the cost of treating musculoskeletal disease.
Sector
Medtech and Medical Devices
Status
Current
Website
https://orthosensor.com
Sirion Therapeutics, Inc.
Sirion developed and commercialized products that addressed unmet medical needs in the protection and preservation of eyesight. Its lead products are now on the market for post-operative inflammation and ocular herpes.
Sector
Specialty Pharma
Status
Exited | Acquired by Alcon and Bausch & Lomb
Synageva BioPharma Corp.
Synageva developed and commercialized therapies for underserved populations with rare conditions and unmet medical needs.
Sector
Biotechnology
Status
Exited | IPO; subsequently acquired by Alexion Pharmaceuticals
TriSalus Life Sciences
TriSalus is an immunotherapy company on a mission to extend and improve the lives of patients living with liver and pancreatic tumors. By integrating an immunotherapeutic with innovative drug delivery technologies, TriSalus’ platform seeks to address two of the most significant barriers that limit the effectiveness of current treatments for liver and pancreatic tumors: immunosuppression and high intratumoral pressure. The company is studying the ability of SD-101, a potentially first-in-class, investigative TLR9 agonist, to reactivate the immune system within the liver and pancreas to enable more durable responses to other immunotherapeutics (e.g., checkpoint inhibitors, CAR T-cell therapy) and improve patient outcomes. The platform, which leverages TriSalus’ proprietary Pressure-Enabled Drug Delivery™ (PEDD™) method of administration, modulates pressure and flow within blood vessels to improve the amount of therapy delivered to the tumor. While meaningful progress in these difficult-to-treat diseases will not be easy, TriSalus is focused on advancing science and technological innovation to transform outcomes for patients.
Sector
Medtech and Medical Devices
Status
Current
Website
https://trisaluslifesci.com
Vidacare Corporation
Vidacare was the developer of intraosseous (inside the bone) medical devices used in vascular access, emergency and disaster medicine, oncology, and spinal surgery and marketed in over 50 countries worldwide. Its EZ-IO technology was used in 90 percent of U.S. advanced life support ambulances, over half of U.S. emergency departments, and by the U.S. military.
Sector
Medtech and Medical Devices
Status
Exited | Acquired by Teleflex